Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes

Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes

Thumbnail Image
Download
Name

Weiss_Preserved DNA Damage Checkpoint.pdf

Size

3.48 MB

Format

Adobe PDF

Checksum (MD5)

98c7d995d9a95cd5dcbe98c0ea695a25

Author(s)
Bhatt, Shweta
•
Gupta, Manoj K.
•
Khamaisi, Mogher
•
Martinez, Rachael
•
Gritsenko, Marina A.
•
Wagner, Bridget K.
•
Guye, Patrick
•
Busskamp, Volker
•
Shirakawa, Jun
•
Wu, Gongxiong
more
Date Issued
May 2015
Journal
Cell Metabolism
Publisher
Elsevier
Citation
Bhatt, Shweta et al. “Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes.” Cell Metabolism 22.2 (2015): 239–252.
Version
Author's final manuscript
Abstract
The mechanisms underlying the development of complications in type 1 diabetes (T1D) are poorly understood. Disease modeling of induced pluripotent stem cells (iPSCs) from patients with longstanding T1D(disease duration ≥ 50 years) with severe (Medalist +C) or absent to mild complications (Medalist −C) revealed impaired growth, reprogramming, and differentiation in Medalist +C. Genomics and proteomics analyses suggested differential regulation of DNA damage checkpoint proteins favoring protection from cellular apoptosis in Medalist −C. In silico analyses showed altered expression patterns of DNA damage checkpoint factors among the Medalist groups to be targets of miR200, whose expression was significantly elevated in Medalist +C serum. Notably, neurons differentiated from Medalist +C iPSCs exhibited enhanced susceptibility to genotoxic stress that worsened upon miR200 overexpression. Furthermore, knockdown of miR200 in Medalist +C fibroblasts and iPSCs rescued checkpoint protein expression and reduced DNA damage. We propose miR200-regulated DNA damage checkpoint pathway as a potential therapeutic target for treating complications of diabetes
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/105338
DOI of Published Version
https://doi.org/10.1016/j.cmet.2015.07.015
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.